M
Mark B. Meyer
Researcher at Mayo Clinic
Publications - 2
Citations - 387
Mark B. Meyer is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Pharmacodynamics & Pharmacokinetics. The author has an hindex of 2, co-authored 2 publications receiving 373 citations.
Papers
More filters
Journal ArticleDOI
Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies
Patricia M. LoRusso,Alex A. Adjei,Mary Varterasian,Shirish Gadgeel,Joel M. Reid,David Y. Mitchell,Lorelei J. Hanson,Pamela DeLuca,Laura M. Bruzek,Jill Piens,Peggy Asbury,Keri Van Becelaere,Roman Herrera,Judith Sebolt-Leopold,Mark B. Meyer +14 more
TL;DR: Both target suppression and antitumor activity were demonstrated in this phase I study of CI-1040, a small-molecule inhibitor of the dual-specificity kinases MEK -1 and MEK2 in patients with advanced malignancy.
Journal ArticleDOI
A novel acute toxicity resulting from the administration of morphine and Adriamycin to mice
TL;DR: The temporal relationship between the elevated hematocrit and early (30 min) mortality suggest a cause/effect relationship between these two events following combined morphine plus Adriamycin treatment, and the toxic potential of the combination of morphine and AdRIamycin has been evaluated in mice.